Hims & Hers Expands Global Footprint with Eucalyptus Acquisition
Event summary
- Hims & Hers completed the acquisition of Eucalyptus, the parent company of Juniper, Pilot, Kin, and Software, on June 2, 2026.
- The acquisition marks Hims & Hers' official entry into the Australian market, positioning it as the world's largest consumer health platform.
- Eucalyptus has served over 550,000 Australians since 2019, addressing health needs ranging from weight management to men’s sexual health.
- Andrew Dudum, CEO of Hims & Hers, and Tim Doyle, former CEO of Eucalyptus, highlight the strategic importance of the acquisition in redefining healthcare access in Australia.
The big picture
The acquisition of Eucalyptus solidifies Hims & Hers' position as a dominant player in the consumer health platform space. This move aligns with the broader trend of digital health companies expanding their reach to address underserved markets and improve healthcare access. The deal underscores the strategic importance of local clinical expertise in global market penetration, particularly in regions with significant healthcare challenges.
What we're watching
- Integration Challenges
- How Hims & Hers will integrate Eucalyptus' brands and operations into its existing platform without disrupting service for over 550,000 Australian customers.
- Market Penetration
- Whether Hims & Hers can leverage Eucalyptus' local clinical approach to further penetrate the Australian healthcare market, where a quarter of consumers face long wait times for appointments.
- Global Expansion
- The pace at which Hims & Hers can expand its unified platform globally, following its successful entry into Australia.
Related topics